| Literature DB >> 30890726 |
Ajeeta Anand1, Hideki Aoyagi2,3.
Abstract
Phosphate binders and dialysis can have harmful side-effects during the treatments of hyperphosphatemia. Therefore, we evaluated the capability of intestinal bacteria (lactic acid bacteria and bifidobacteria) as phosphate-accumulating organisms (PAOs) for phosphate accumulation, with the aim of determining whether PAO-formulated food can prevent hyperphosphatemia in the early stages. However, methods for estimating microbial phosphate-accumulation capacities require significant improvements regarding specificity, cost, and simplicity. The presented method analyzed cell-free broth to assess the phosphate accumulation capability of cells. Active cells and the constructed phosphate-deficient cells were incubated in assay salt media. After incubation, phosphate-deficient cell-free broth was taken as sample and the blank was the active cell-free broth. Therefore, effects of interfering agents and other metabolites were avoided and enhanced the specificity remarkably. Phosphate contents were assessed by reactions with toluidine blue O. In contrast to the case in previous studies, the shift in the first absorbance peak was found to be inversely proportional to the phosphate concentration. The minimum detectable phosphate concentrations for the 11th isolate of Lactobacillus casei JCM 1134 and 8th isolate of Bifidobacterium adolescentis JCM 1275 were determined to be 1.24 and 0.4 mg/L, respectively. Further, the validation results were found to be significant (p-value < 0.05).Entities:
Mesh:
Substances:
Year: 2019 PMID: 30890726 PMCID: PMC6425018 DOI: 10.1038/s41598-018-37752-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Growth of cells incubated in transformation medium (that convert phosphate rich to phosphate deficient cells) were monitored over time where optical density (OD) and pH data are represented.
| Probiotic | L11 of | B8 of | ||
|---|---|---|---|---|
| Time (h) | OD at 680 nm | pH | OD at 680 nm | pH |
| 0 | 7.20 ± 0.020 | 6.01 ± 0.01 | 5.80 ± 0.002 | 6.02 ± 0.01 |
| 1 | 7.22 ± 0.010 | 6.05 ± 0.03 | 5.84 ± 0.005 | 6.01 ± 0.03 |
| 2 | 7.21 ± 0.002 | 6.03 ± 0.01 | 5.78 ± 0.012 | 5.94 ± 0.02 |
| 4 | 7.32 ± 0.012 | 5.98 ± 0.02 | 5.68 ± 0.002 | 5.87 ± 0.02 |
| 6 | 7.29 ± 0.004 | 5.91 ± 0.01 | 5.56 ± 0.008 | 5.82 ± 0.01 |
| 8 | 7.21 ± 0.010 | 5.86 ± 0.02 | 5.40 ± 0.010 | 5.77 ± 0.01 |
Metabolic activities of cells incubated in transformation medium where CFU/L values and sugar and phosphate contents are represented.
| Probiotic | L11 of | B8 of | ||||
|---|---|---|---|---|---|---|
| Time (h) | CFU (1011) /L | Sugar content (μg/mg-dcw) | Phosphate content (mg/mg-dcw) | CFU (108) /L | Sugar content (μg/mg-dcw) | Phosphate content (mg/mg-dcw) |
| 0* | 9.84 ± 0.02 | 36.5 ± 0.1 | 0.84 ± 0.03 | 8.92 ± 0.03 | 32.1 ± 0.1 | 0.73 ± 0.02 |
| 8* | 9.39 ± 0.01 | 36.7 ± 0.0 | 0.33 ± 0.02 | 8.80 ± 0.02 | 32.4 ± 0.1 | 0.21 ± 0.01 |
| 0# | 9.95 ± 0.01 | 36.4 ± 0.1 | 0.82 ± 0.02 | 8.95 ± 0.01 | 32.2 ± 0.0 | 0.75 ± 0.01 |
| 8# | 9.87 ± 0.02 | 36.5 ± 0.1 | 0.79 ± 0.01 | 8.86 ± 0.02 | 32.2 ± 0.0 | 0.72 ± 0.01 |
Transformation medium and ice box are denoted by (*) and (#), respectively. Numerical values are expressed with standard deviations while “dcw” stands for dry cell weight.
Figure 1Metabolic activities of cells incubated in assay salt solution (which evaluated the phosphate accumulation abilities of cells) and monitored over time: (a) phosphate contents of supernatants of cells incubated in assay salt broth [(+P): ◊→L11 of L. casei JCM 1134 and •→B8 of B. adolescentis JCM 1275]. Standard errors are less than 8%. (b) Pre- and post-incubation DAPI micrographs of probiotics; b.1, b.2, b.5, and b.6 were incubated in phosphate-containing assay salt solution while b.3, b.4, b.7, and b.8 were incubated in phosphate-free assay salt solution. b.1→ at 0 h phosphate-deficient L11 of L. casei JCM1134, b.2→ at 6 h L11 of L. casei JCM1134 (phosphate metabolising), b.3→ at 0 h active L11 of L. casei JCM1134, b.4→ at 6 h L11 of B8 of B. adolescentis JCM1275 (phosphate storing), b.5→ at 0 h phosphate-deficient B8 of B. adolescentis JCM1275, b.6→ at 6 h B8 of B. adolescentis JCM1275 (phosphate metabolising), b.7→ at 0 h active B8 of B. adolescentis JCM1275, b.8→ at 6 h B8 of B. adolescentis JCM 1275 (phosphate storing). White bars represent 2 μm.
Metabolic activities of PAOs in assay salt solution and were monitored over time where optical density (OD) and pH data are represented.
| Probiotic | L11 of | B8 of | ||||||
|---|---|---|---|---|---|---|---|---|
| Assay solution | +P | +NaCl | +P | +NaCl | ||||
| Time (h) | OD at 680 nm | pH | OD at 680 nm | pH | OD at 680 nm | pH | OD at 680 nm | pH |
| 0 | 6.90 ± 0.020 | 6.02 ± 0.02 | 7.00 ± 0.003 | 6.01 ± 0.02 | 5.40 ± 0.013 | 6.03 ± 0.02 | 6.02 ± 0.002 | 6.01 ± 0.02 |
| 1 | 6.88 ± 0.010 | 6.04 ± 0.02 | 6.98 ± 0.020 | 6.02 ± 0.01 | 5.38 ± 0.004 | 6.03 ± 0.01 | 5.95 ± 0.001 | 6.02 ± 0.01 |
| 2 | 6.89 ± 0.012 | 6.01 ± 0.01 | 6.90 ± 0.014 | 6.00 ± 0.01 | 5.37 ± 0.006 | 6.00 ± 0.01 | 5.96 ± 0.012 | 5.98 ± 0.01 |
| 4 | 6.86 ± 0.006 | 5.99 ± 0.01 | 6.81 ± 0.016 | 5.98 ± 0.02 | 5.35 ± 0.004 | 5.97 ± 0.02 | 5.93 ± 0.011 | 5.94 ± 0.01 |
| 6 | 6.81 ± 0.002 | 6.17 ± 0.01 | 6.89 ± 0.009 | 6.10 ± 0.03 | 5.23 ± 0.005 | 5.89 ± 0.03 | 5.98 ± 0.013 | 6.03 ± 0.03 |
| 8 | 5.60 ± 0.006 | 6.23 ± 0.03 | 5.83 ± 0.004 | 6.18 ± 0.01 | 4.89 ± 0.002 | 5.82 ± 0.01 | 6.09 ± 0.011 | 6.16 ± 0.02 |
Figure 2Absorbance scans of reaction product (a and b; TBO and phosphate in concentration of 2 mg/L in cell-free broth). Net absorbances and shifts in wavelengths of first peaks were used to determine calibration curves (c, d). (a) and (c) are for L. casei JCM 1134 while (b) and (d) are for B. adolescentis JCM 1275. In (a) and (b), white dots → sample, black dots → blank, and grey dots → net absorbance. In (c) and (d), black circles → change in wavelength and black squares → net absorbance. Standard errors of observed values were found less than 2%.
Phosphate contents (mg/mL, ascorbic acid method) were compared with TBO-based phosphate estimates at different time intervals of incubation in assay salt solution for L11 isolate of L. casei JCM 1134 where p < 0.05, t critical value = 18.512 with double-tailed test, F-critical = 12.706, and n = 3.
| Time (h) | TBO P estimation | Ascorbic acid method | F value | t-value | P-value |
|---|---|---|---|---|---|
| 1 | 9.73 ± 0.02 | 9.52 ± 0.03 | 6.90 | 0.174 | 0.120 |
| 2 | 5.73 ± 0.03 | 5.50 ± 0.03 | 8.80 | 0.266 | 0.097 |
| 4 | 0.40 ± 0.02 | 0.38 ± 0.03 | 9.85 | 0.156 | 0.088 |
| 6 | −2.27 ± 0.03 | −2.17 ± 0.01 | 4.11 | 0.250 | 0.180 |
Phosphate contents (mg/mL, ascorbic acid method) were compared with TBO-based phosphate estimates at different time intervals of incubation in assay salt solution for B8 isolate of B. adolescentis JCM 1275 where p < 0.05, t critical value = 12.706, F-critical = 18.512 with double-tailed test, and n = 3.
| Time (h) | TBO P estimation | Ascorbic acid method | F value | t-value | P-value |
|---|---|---|---|---|---|
| 1 | 6.75 ± 0.01 | 6.65 ± 0.03 | 0.89 | 0.384 | 0.445 |
| 2 | 4.68 ± 0.01 | 4.50 ± 0.02 | 4.39 | 0.217 | 0.171 |
| 4 | 1.24 ± 0.02 | 1.18 ± 0.02 | 1.02 | 0.602 | 0.418 |
Composition of transformation media in 0.1M citrate buffer (pH 6.0).
| Ingredients % (w/v) | L11 of | B8 of |
|---|---|---|
| Glucose | 5.0 | 3.0 |
| NaNO3 | 0.5 | 0.25 |
| MgSO4 | 0.05 | 0.05 |
| Tween 80 | 0.1 | 0.1 |
| pH | 6.0 | 6.0 |
Composition of assay salt solution in 0.1M citrate buffer (pH 6.0).
| Ingredients % (w/v) | L11 of | B8 of |
|---|---|---|
| NaNO3 | 0.8 | 0.8 |
| MgSO4 | 0.6 | 0.6 |
| K2HPO4/NaCl | 2.0/1.0 | 1.3/0.6 |
| Tween 80 | 0.1 | 0.1 |
| pH | 6.0 | 6.0 |